MET and hereditary clear cell renal cell carcinoma: Because Akt acts as the main mediator of the c-Met signaling pathway [3], we investigated Akt signaling activity to evaluate the agonist activity of c-Met antibodies in the Caki1 renal cell carcinoma cell line (Figure 4a).